Research Articles
The Green Alchemists: How a Humble Fungus is Transforming Rough Jute into Silky Gold
Discover how Aspergillus nidulans cellulase enzymes are revolutionizing jute processing, turning coarse fibers into luxury textiles while reducing environmental impact.
The sFlt-1 Enigma: How a Tiny Protein Fragment Could Revolutionize Diabetes and Vascular Disease Treatment
Exploring how sFlt-1 protein fragment protects blood vessels from diabetes damage by modulating ERK1/2 pathway under high glucose and hypoxia conditions.
The Silent Superpower of Microbes: How Bacterial "Voting Systems" Create Better Biocatalysts
Discover how quorum sensing transforms microbial communities into industrial powerhouses, revolutionizing wastewater treatment and biofuel production.
Unlocking Nature's Shield Against Alzheimer's: The Ferulago angulata Breakthrough
Discover how Ferulago angulata extract protects brain cells against beta-amyloid toxicity in Alzheimer's disease through multi-target mechanisms.
Unlocking Parkinson's: How Digital Drug Hunters Are Designing Hope in a Lab
Discover how ligand-based modelling is revolutionizing Parkinson's drug discovery by identifying potent small molecule inhibitors through advanced computational techniques.
The Double-Edged Sword: How a Common Food Preservative Fights DNA Damage While Raising Safety Questions
Exploring the dual role of BHA in protecting against DNA damage from carcinogen MNNG while raising safety concerns at different doses.
The Invisible Inheritance: How Parental Diabetes Reshapes a Child's Metabolic Destiny
Exploring how children of diabetic parents carry invisible metabolic signatures that alter their bodies' sugar processing, fat storage, and inflammation responses.
The ACE Inhibitor Puzzle: Why a Heart Drug Works Differently in Japan
Exploring why ACE inhibitors show different effectiveness in Japanese heart attack patients compared to Western populations.
Digital Drug Hunters: How Computational Methods Are Revolutionizing the Fight Against Leishmaniasis
Exploring how in-silico methods are transforming antileishmanial drug discovery through computational approaches like molecular docking and AI-driven target identification.